The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I clinical trial of peposertib plus radiation in adults with newly diagnosed MGMT-unmethylated glioblastoma.
 
Nazanin Majd
Consulting or Advisory Role - Baxter (I); Celularity; Sumitomo Dainippon Pharma Co., Ltd. Consulting
 
Debra Yeboa
Research Funding - 1% FTE to institution (non-PI site collaborator) Novartis
 
Shuqi Wang
No Relationships to Disclose
 
Shiao-Pei S. Weathers
Research Funding - Exelixis; Genentech/Roche (Inst); Mundipharma (Inst)
 
Ying Yuan
Consulting or Advisory Role - A2 Biotherapeutics; Abbvie; Amgen; Ascendis Pharma; Bexion; BeyondSpring Pharmaceuticals; Boehringer Ingelheim; Bristol-Myers Squibb/Celgene/Juno; Century Therapeutics; Enliven Therapeutics; GT Medical Technologies; NeoImmuneTech; NGM Biopharmaceuticals; Repare Therapeutics; SERVIER; Starpax Medical; Vertex
 
Haider Al Anssari
No Relationships to Disclose
 
Carlos Kamiya-Matsuoka
No Relationships to Disclose
 
Barbara Jane O'Brien
Consulting or Advisory Role - Plus Therapeutics
Research Funding - EMD Serono (Inst); Kintara (Inst)
 
Ashley Aaroe
No Relationships to Disclose
 
Chirag B Patel
Honoraria - College of American Pathologists; Research to Practice
Consulting or Advisory Role - Novocure
Research Funding - Novocure (Inst)
Patents, Royalties, Other Intellectual Property - Patent application with Novocure, Ltd.
Travel, Accommodations, Expenses - Novocure
(OPTIONAL) Uncompensated Relationships - BMC Neuroscience; National Brain Tumor Registry of China (NBTRC)
 
Samir Dagher
No Relationships to Disclose
 
Max Wintermark
No Relationships to Disclose
 
Sherise D. Ferguson
No Relationships to Disclose
 
Vinay K. Puduvalli
Stock and Other Ownership Interests - Gilead Sciences
Honoraria - Bayer; Guidepoint Inc; InSightec; Novocure; Orbus Therapeutics; SERVIER; Tango Therapeutics; Telix Pharmaceuticals
Consulting or Advisory Role - Bayer; Guidepoint Inc; InSightec; Newave Pharmaceutical (I); Novocure; Orbus Therapeutics; SERVIER; Tango Therapeutics; Telix Pharmaceuticals
Research Funding - Bexion; InSightec; Karyopharm Therapeutics; Kazia Therapeutics; Merck; Radiomedix; Samus Therapeutics; SERVIER
 
Siyuan John Liu
Employment - University of San Francisco
Patents, Royalties, Other Intellectual Property - University of San Francisco
 
David R. Raleigh
Honoraria - Gamma Tile; Tipping Point
 
John Frederick de Groot
Employment - Alaunos Therapeutics (I); Brii Biosciences (I)
Stock and Other Ownership Interests - Alaunos Therapeutics (I); Brii Biosciences (I); WuXi Biologics
Consulting or Advisory Role - Alpha Pharmaceutical; Aucentra Therapeutics; Bioasis Technologies; CarThera; Chimerix; Cure Brain Cancer Foundation; InSightec; Karyopharm Therapeutics; Kazia Therapeutics; Kintara Therapeutics; Merck; Midatech Pharma; Monteris Medical; Mundipharma Research; Samus Therapeutics; Sapience Therapeutics; SERVIER; Sumitomo Dainippon Pharma Oncology; Telix Pharmaceuticals; VBI Vaccines
Research Funding - CarThera (Inst); Haihe Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)
Other Relationship - Chimerix; VBI Vaccines